SKIN TO IT Podcast podcast

Ep #39 More Than Just Flakes: Seborrheic Dermatitis, Dandruff, and the FDA-Approved Treatment Changing Everything

0:00
21:41
Retroceder 15 segundos
Avanzar 15 segundos

Is dandruff really just dry skin? Not quite.


In this episode, Dr. Sandy Skotnicki and Marlo Sutton break down the science behind seborrheic dermatitis—a common but often misunderstood inflammatory condition that causes persistent scalp and facial flaking, redness, and irritation.


This episode is sponsored by Arcutis, developer of targeted dermatology therapies such as roflumilast.


Listeners will learn:

  • Why seborrheic dermatitis is more than dandruff—it’s driven by oil production, yeast (Malassezia), and inflammation
  • What it actually looks like across different skin types
  • Why traditional treatments like antifungal shampoos and steroids don’t always provide lasting control
  • The emerging issue of antifungal resistance
  • How roflumilast (a topical PDE-4 inhibitor) works differently by targeting inflammation, not just yeast
  • What the clinical trials show, including fast results and strong long-term outcomes
  • Why this new approach may represent a shift in how we treat chronic scalp conditions


The takeaway? Seborrheic dermatitis is a chronic condition—but with newer treatments targeting inflammation, long-term control is becoming more achievable than ever.


Every Thursday on Skin to It, dermatologist Dr. Sandy Skotnicki and beauty enthusiast Marlo Sutton guide you through the maze of skincare, cutting through the noise to help you achieve your healthiest skin. Subscribe to ensure you never miss out on our skincare wisdom!


Love our podcast? Tell us what you love about the show to help others discover it too, by sharing your review.


Skin to It is a skincare podcast brought to you by Bioderma.


For more information about Skin to It, visit skintoitpodcast.com.


Follow us on social media at Dr. Sandy Skotnicki and Marlo Sutton.

Otros episodios de "SKIN TO IT Podcast"